Last month, New York City officials announced they had identified the remains of another three victims who died in the Sept. 11 attacks at the World Trade Center in lower Manhattan. It was the latest ...

Aven, a startup aimed at homeowners who want to tap their equity without the hassle of a traditional loan, has secured some fresh funds of its own. The San Francisco-based fintech raised $110 million ...

There’s been great interest in what Mira Murati’s Thinking Machines Lab is building with its $2 billion in seed funding and the all-star team of former OpenAI researchers who have joined the lab. In a ...

HONOLULU (KHON2) — The deadline to comment on the future of a prime spot in Manoa is Friday. Two of the three tenants are set to leave, but University Lab School wants supporters to speak up before a ...

OFM projects tariffs could cost Washington $2.2B and 31,900 jobs by 2029 Report: Tariffs may spell 16% food price increase, 25% used car surge, and 7% apparel rise Republican lawmakers challenge OFM ...

After 15 years, King of the Hill returned to television with a very warm welcome from audiences as the 10 new episodes helped drive 1.21B minutes of streaming on Hulu from August 4 to 10, according to ...

Harvard University scored a major legal victory in its battle with the Trump administration after a court ruled that the US illegally froze more than $2 billion in research funding. The US government ...

Mega Matrix, a publicly traded holding company that has shifted into digital assets, filed a $2 billion shelf registration with the US Securities and Exchange Commission (SEC) to fund a ...

The judge said the Trump administration "used antisemitism as a smokescreen." A federal judge on Wednesday stopped the Trump administration's attempt to axe $2.2 billion in research funding for ...

Gemini, the U.S.-based crypto exchange led by the Winklevoss twins, is eyeing a valuation of up to $2.22 billion in its initial public offering (IPO), the company said on Sep. 2. The crypto exchange ...

Novartis has agreed to license and develop Arrowhead Pharmaceuticals’ preclinical stage small interfering RNA (siRNA) therapy ARO-SNCA, a potential treatment for Parkinson’s disease and other ...